Bonaventure Equity, LLC β Full Portfolio
8 tracked investments Β· listed companies and verified rows first
Engineered Medical develops handheld spectrometers for measuring chemical compounds in agricultural and food products, including cannabinoids, phenolics, and contaminants.
AgTechFoodTech
FloraWorks develops rare and novel cannabinoid-based therapeutic ingredients, focusing on non-intoxicating cannabinoids validated through peer-reviewed research and toxicology testing.
BiotechHealthtechWellness & Fitness
Alleh Lindquist(CEO)in
LeafWorks conducts plant genomics research linking genotypes to agriculturally and commercially relevant traits, and develops DNA-based tests and services for genetic identification of botanical species.
AgTechBiotechDeep TechSebastopol, US
Kerin Law(Executive Officer, Director)inEleanor Kuntz(Executive Officer, Director)inWilliam Kehoe(Executive Officer)Kerin Bentley(Executive Officer, Director)
Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Caitlyn Krebs(Co-founder + CEO)inPhyllis Whiteley(Co-founder + Board Member)inRandall Ussery(Co-founder + Board Member)Howard Goodwin(Director)
Co-investorsFlybridge Capital PartnersPortfoliaGolden Seeds
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US
Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)inScott Rairigh(EVP, Corporate Development)inMagali Haas(Chief Medical Officer)in
Co-investorsIter InvestmentsMystic Ventures
Sensa Neuroscience is a drug development company creating SEN126, a CBD-derived analog designed to treat refractory epilepsy, including Developmental and Epileptic Encephalopathies (DEEs).
BiotechMedical Devices
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsHatteras Venture PartnersIter InvestmentsMission BiocapitalRoute 66 VenturesService Provider CapitalSante Health Ventures+1 more
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.